Straumann Holding AG (OTCMKTS:SAUHY) Receives Average Recommendation of “Hold” from Brokerages

Posted by George Bondi on Sep 8th, 2026

Shares of Straumann Holding AG (OTCMKTS:SAUHY – Get Free Report) have earned a consensus recommendation of “Hold” from the seven ratings firms that are covering the firm, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell rating, two have given a hold rating and three have assigned a buy rating to the company.

A number of research analysts have recently commented on the stock. BMO Capital Markets started coverage on shares of Straumann in a research report on Wednesday, July 8th. They set an “outperform” rating for the company. Deutsche Bank Aktiengesellschaft lowered Straumann from a “buy” rating to a “hold” rating in a research note on Friday, August 21st. Morgan Stanley restated an “underweight” rating on shares of Straumann in a research report on Tuesday, June 30th. UBS Group upgraded Straumann from a “neutral” rating to a “buy” rating in a research note on Tuesday, September 1st. Finally, Citigroup reaffirmed a “sell” rating on shares of Straumann in a report on Thursday, July 9th.

Get Our Latest Research Report on SAUHY

Straumann Price Performance

Straumann stock opened at $11.53 on Tuesday. Straumann has a 1-year low of $9.44 and a 1-year high of $13.61. The firm’s 50 day simple moving average is $12.32 and its 200 day simple moving average is $11.63.

Straumann Company Profile

(Get Free Report)

Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.

In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.